Physician profile
Henry Chou
NPI 1619312725
$8,683.01
in general payments reported to CMS, 2019-2025
21 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $135 · 2021: $240 · 2022: $3,289 · 2023: $2,856 · 2024: $994 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,208 · Travel and Lodging: $1,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,207.75 |
| Travel and Lodging | $1,780.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,500.82 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $708.88 | 2019-2020 | |
| Si-Bone, INC. | $291.59 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $228.89 | 2022-2024 | |
| Abbott Laboratories | $153.76 | 2019-2022 | |
| Ibsa Pharma INC. | $134.36 | 2020-2023 | Tirosint, Licart |
| Merz North America, INC. | $96.69 | 2019-2020 | |
| Orthofix Medical, INC. | $96.27 | 2020-2025 | Physio-Stim |
| Boston Scientific Corporation | $68.35 | 2019 | |
| Pfizer INC. | $59.36 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $50.12 | 2021 | |
| Bioventus LLC | $44.54 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $40.51 | 2023-2025 | Horizant, Edarbi |
| Zimmer Biomet Holdings, INC. | $34.91 | 2024-2025 | Gps III Platelet Concentration System |
| Depuy Synthes Sales INC. | $34.45 | 2024 | Monovisc |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $33.92 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.94 | 2019 | |
| Pacira Therapeutics, INC. | $26.45 | 2019 | |
| Amgen INC. | $19.79 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.50 | 2022 | |
| Curonix LLC | $12.91 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.